| Identification | Back Directory | [Name]
PRI-724 | [CAS]
1198780-43-6 | [Synonyms]
PRI-724 C-82,C82 (6S,9S)-N-benzyl-6-(4-hydroxybenzyl)-2,9-dimethyl-4,7-dioxo-8-(quinolin-8-ylmethyl) hexahydro-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide 2H-Pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide, hexahydro-6-[(4-hydroxyphenyl)methyl]-2,9-dimethyl-4,7-dioxo-N-(phenylmethyl)-8-(8-quinolinylmethyl)-, (6S,9S)- | [Molecular Formula]
C33H34N6O4 | [MDL Number]
MFCD32664544 | [MOL File]
1198780-43-6.mol | [Molecular Weight]
578.66 |
| Hazard Information | Back Directory | [Uses]
PRI 724 is a studied as a prospect for safely and effectively targeting catenin coactivator antagonism interactions to eliminate cancer stem cell population in human cancer. |
|
|